GalNAc-L96 (CAS 1159408-62-4) is a triantennary GalNAc ligand that can be used for the synthesis of GalNAc-siRNA[1]. GalNAc is a ligand of ASGPR (asialoglycoprotein receptor). And Watson leverages cutting-edge glycochemistry and nucleic acid modification technologies to provide high-purity, high-quality GalNAc-L96 and its derivatives, ensuring optimal outcomes in RNAi and ASO drug development.
Be the first to comment